相似文献
1
The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS-CoV-2 and Cytokine Storm.
Chem Biodivers. 2022 Nov;19(11):e202200655. doi: 10.1002/cbdv.202200655. Epub 2022 Oct 10.
2
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
3
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130.
4
Identification of bioactive molecule from (Ashwagandha) as SARS-CoV-2 main protease inhibitor.
J Biomol Struct Dyn. 2021 Sep;39(15):5668-5681. doi: 10.1080/07391102.2020.1790425. Epub 2020 Jul 8.
5
Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
Comput Biol Med. 2021 Sep;136:104683. doi: 10.1016/j.compbiomed.2021.104683. Epub 2021 Jul 24.
6
Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
Curr Pharm Biotechnol. 2021;22(4):444-450. doi: 10.2174/1389201021666200703201458.
7
analysis of phytochemicals as potential inhibitors of proteases involved in SARS-CoV-2 infection.
J Biomol Struct Dyn. 2022 Jul;40(11):5053-5059. doi: 10.1080/07391102.2020.1866669. Epub 2020 Dec 29.
8
Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").
Med Chem. 2022;18(3):364-381. doi: 10.2174/1573406417666210618132003.
9
(L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy.
Front Cell Infect Microbiol. 2022 Aug 15;12:933824. doi: 10.3389/fcimb.2022.933824. eCollection 2022.
10
Medicinal plant compounds as promising inhibitors of coronavirus (COVID-19) main protease: an study.
J Biomol Struct Dyn. 2022 Oct;40(17):8073-8084. doi: 10.1080/07391102.2021.1906749. Epub 2021 May 10.
引用本文的文献
1
Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M protein - an in silico and cell-based approach.
Sci Rep. 2025 Jul 2;15(1):22840. doi: 10.1038/s41598-025-05907-z.
2
Production of Phytoplacenta Extract and Potential Applications in Skincare.
Life (Basel). 2025 Mar 3;15(3):397. doi: 10.3390/life15030397.
3
Efficacy of Licorice as Adjunctive Therapy in Critically Ill Patients with COVID-19: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
J Res Pharm Pract. 2024 Aug 8;12(4):141-147. doi: 10.4103/jrpp.jrpp_22_24. eCollection 2023 Oct-Dec.
4
Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus.
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2390909. doi: 10.1080/14756366.2024.2390909. Epub 2024 Aug 29.
5
Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents.
Nutrients. 2023 Nov 8;15(22):4719. doi: 10.3390/nu15224719.
6
Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Nutrients. 2023 Sep 6;15(18):3885. doi: 10.3390/nu15183885.
7
A potential host and virus targeting tool against COVID-19: Chemical characterization, antiviral, cytoprotective, antioxidant, respiratory smooth muscle relaxant effects of Paulownia tomentosa Steud.
Biomed Pharmacother. 2023 Feb;158:114083. doi: 10.1016/j.biopha.2022.114083. Epub 2022 Dec 5.
Zotero 插件